Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 26 |
NetGPI | no | yes: 0, no: 26 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: Q4Q0G8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.439 |
CLV_NRD_NRD_1 | 64 | 66 | PF00675 | 0.472 |
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.451 |
CLV_NRD_NRD_1 | 94 | 96 | PF00675 | 0.440 |
CLV_PCSK_KEX2_1 | 145 | 147 | PF00082 | 0.762 |
CLV_PCSK_KEX2_1 | 34 | 36 | PF00082 | 0.381 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.435 |
CLV_PCSK_KEX2_1 | 56 | 58 | PF00082 | 0.426 |
CLV_PCSK_KEX2_1 | 68 | 70 | PF00082 | 0.478 |
CLV_PCSK_KEX2_1 | 96 | 98 | PF00082 | 0.419 |
CLV_PCSK_PC1ET2_1 | 145 | 147 | PF00082 | 0.762 |
CLV_PCSK_PC1ET2_1 | 34 | 36 | PF00082 | 0.412 |
CLV_PCSK_PC1ET2_1 | 56 | 58 | PF00082 | 0.455 |
CLV_PCSK_PC1ET2_1 | 68 | 70 | PF00082 | 0.506 |
CLV_PCSK_PC1ET2_1 | 96 | 98 | PF00082 | 0.419 |
CLV_PCSK_PC7_1 | 52 | 58 | PF00082 | 0.413 |
CLV_PCSK_SKI1_1 | 117 | 121 | PF00082 | 0.587 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.457 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.582 |
CLV_PCSK_SKI1_1 | 142 | 146 | PF00082 | 0.635 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.522 |
DOC_CYCLIN_yCln2_LP_2 | 107 | 113 | PF00134 | 0.555 |
DOC_USP7_MATH_1 | 138 | 142 | PF00917 | 0.465 |
DOC_USP7_MATH_1 | 154 | 158 | PF00917 | 0.678 |
DOC_USP7_UBL2_3 | 131 | 135 | PF12436 | 0.608 |
DOC_USP7_UBL2_3 | 136 | 140 | PF12436 | 0.578 |
DOC_USP7_UBL2_3 | 151 | 155 | PF12436 | 0.712 |
DOC_USP7_UBL2_3 | 156 | 160 | PF12436 | 0.694 |
DOC_USP7_UBL2_3 | 37 | 41 | PF12436 | 0.422 |
DOC_WW_Pin1_4 | 150 | 155 | PF00397 | 0.689 |
DOC_WW_Pin1_4 | 9 | 14 | PF00397 | 0.427 |
LIG_14-3-3_CanoR_1 | 74 | 82 | PF00244 | 0.500 |
LIG_14-3-3_CanoR_1 | 95 | 105 | PF00244 | 0.441 |
LIG_FHA_1 | 114 | 120 | PF00498 | 0.557 |
LIG_LIR_Gen_1 | 12 | 19 | PF02991 | 0.366 |
LIG_LIR_Gen_1 | 76 | 86 | PF02991 | 0.406 |
LIG_LIR_Nem_3 | 12 | 17 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 40 | 46 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 76 | 81 | PF02991 | 0.413 |
LIG_SH2_CRK | 86 | 90 | PF00017 | 0.330 |
LIG_UBA3_1 | 38 | 44 | PF00899 | 0.435 |
LIG_WW_3 | 71 | 75 | PF00397 | 0.472 |
MOD_CDK_SPK_2 | 150 | 155 | PF00069 | 0.689 |
MOD_CDK_SPxK_1 | 150 | 156 | PF00069 | 0.473 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.367 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.469 |
MOD_CK1_1 | 99 | 105 | PF00069 | 0.461 |
MOD_Cter_Amidation | 158 | 161 | PF01082 | 0.659 |
MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.641 |
MOD_GlcNHglycan | 98 | 101 | PF01048 | 0.454 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.617 |
MOD_GSK3_1 | 136 | 143 | PF00069 | 0.675 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.651 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.424 |
MOD_NEK2_1 | 64 | 69 | PF00069 | 0.393 |
MOD_PIKK_1 | 44 | 50 | PF00454 | 0.441 |
MOD_PIKK_1 | 99 | 105 | PF00454 | 0.383 |
MOD_PKA_1 | 125 | 131 | PF00069 | 0.496 |
MOD_PKA_1 | 155 | 161 | PF00069 | 0.647 |
MOD_PKA_1 | 96 | 102 | PF00069 | 0.473 |
MOD_PKA_2 | 64 | 70 | PF00069 | 0.504 |
MOD_PKA_2 | 73 | 79 | PF00069 | 0.581 |
MOD_PKA_2 | 96 | 102 | PF00069 | 0.427 |
MOD_ProDKin_1 | 150 | 156 | PF00069 | 0.690 |
MOD_ProDKin_1 | 9 | 15 | PF00069 | 0.426 |
TRG_DiLeu_BaEn_2 | 76 | 82 | PF01217 | 0.442 |
TRG_DiLeu_BaLyEn_6 | 3 | 8 | PF01217 | 0.472 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.410 |
TRG_ENDOCYTIC_2 | 86 | 89 | PF00928 | 0.371 |
TRG_ER_diArg_1 | 69 | 72 | PF00400 | 0.592 |
TRG_ER_diArg_1 | 94 | 97 | PF00400 | 0.444 |
TRG_NLS_Bipartite_1 | 135 | 149 | PF00514 | 0.505 |
TRG_NLS_Bipartite_1 | 51 | 72 | PF00514 | 0.498 |
TRG_NLS_MonoExtC_3 | 64 | 69 | PF00514 | 0.577 |
TRG_NLS_MonoExtN_4 | 142 | 149 | PF00514 | 0.751 |
TRG_NLS_MonoExtN_4 | 62 | 69 | PF00514 | 0.584 |
TRG_Pf-PMV_PEXEL_1 | 117 | 121 | PF00026 | 0.577 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I8Y9 | Leptomonas seymouri | 70% | 95% |
A0A0N1IC67 | Leptomonas seymouri | 34% | 100% |
A0A0S4IRH7 | Bodo saltans | 34% | 100% |
A0A0S4J9G1 | Bodo saltans | 33% | 100% |
A0A0S4JC95 | Bodo saltans | 32% | 100% |
A0A0S4JL06 | Bodo saltans | 30% | 100% |
A0A1X0NLS3 | Trypanosomatidae | 39% | 100% |
A0A1X0NNA1 | Trypanosomatidae | 62% | 90% |
A0A1X0NNA5 | Trypanosomatidae | 39% | 100% |
A0A1X0NND5 | Trypanosomatidae | 36% | 100% |
A0A3Q8ILR8 | Leishmania donovani | 37% | 100% |
A0A3Q8IPT9 | Leishmania donovani | 93% | 100% |
A0A3R7MMA3 | Trypanosoma rangeli | 36% | 100% |
A0A3R7NF04 | Trypanosoma rangeli | 55% | 86% |
A0A422NSG2 | Trypanosoma rangeli | 35% | 100% |
A0A422NSJ6 | Trypanosoma rangeli | 36% | 100% |
A4HQA1 | Leishmania braziliensis | 35% | 100% |
A4HQA9 | Leishmania braziliensis | 88% | 97% |
A4IDZ7 | Leishmania infantum | 37% | 100% |
A4IE05 | Leishmania infantum | 93% | 100% |
D0A3Z6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 77% |
D0A408 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 87% |
D0A410 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
E9AU19 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% |
E9AU27 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 99% |
Q07053 | Crithidia fasciculata | 33% | 100% |
Q4Q0H6 | Leishmania major | 37% | 100% |
V5BT80 | Trypanosoma cruzi | 57% | 87% |
V5DK57 | Trypanosoma cruzi | 34% | 100% |